Peptide and Anticoagulant Drugs Market Size, Share, And Growth Report 2032

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global Peptide and Anticoagulant Drugs Market Revenue, 2016-2025 (USD Million)
  • 2.2. Global Peptide and Anticoagulant Drugs Market: Snapshot
•  
• Chapter 3. Peptide and Anticoagulant Drugs Market - Industry Dynamics
  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Global Peptide and Anticoagulant Drugs Market Drivers: Impact Analysis
    • 3.2.2. Increasing prevalence of chronic diseases
    • 3.2.3. Rising population
    • 3.2.4. Government support
    • 3.2.5. Increasing healthcare expenditure
  • 3.3. Market restraints
    • 3.3.1. Availability of alternative drugs
  • 3.4. Opportunities
    • 3.4.1. Emerging markets
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by Type
    • 3.6.2. Market attractiveness analysis, by Low molecular Heparin weight type
    • 3.6.3. Market attractiveness analysis, by Application
    • 3.6.4. Market attractiveness analysis, by Region
•  
• Chapter 4. Global Peptide and Anticoagulant Drugs Market - Competitive Landscape
  • 4.1. Company Market Share Analysis
    • 4.1.1. Global Peptide and Anticoagulant Drugs Market: Company Market Share, 2018
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Product Launch
    • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
    • 4.2.4. Research and Development and Regional Expansion
•  
• Chapter 5. Global Peptide and Anticoagulant Drugs Market - Type Analysis
  • 5.1. Global Peptide and Anticoagulant Drugs Market: type overview
    • 5.1.1. Global Peptide and Anticoagulant Drugs Market Share, by type, 2018 and 2025
  • 5.2. Antifungal
    • 5.2.1. Global Peptide and Anticoagulant Drugs Market for Antifungal, 2016-2025 (USD Million)
  • 5.3. Hormonal
    • 5.3.1. Global Peptide and Anticoagulant Drugs Market for hormonal, 2016-2025 (USD Million)
  • 5.4. Ace inhibitors
    • 5.4.1. Global Peptide and Anticoagulant Drugs Market for Ace inhibitors, 2016-2025 (USD Million)
  • 5.5. Antibiotic
    • 5.5.1. Global Peptide and Anticoagulant Drugs Market for Antibiotic, 2016-2025 (USD Million)
  • 5.6. Other drugs
    • 5.6.1. Global Peptide and Anticoagulant Drugs Market for Other drugs, 2016-2025 (USD Million)
•  
• Chapter 6. Global Peptide and Anticoagulant Drugs Market - Low Molecular Heparin Type Analysis
  • 6.1. Global Peptide and Anticoagulant Drugs Market: Low molecular Heparin type overview
    • 6.1.1. Global Peptide and Anticoagulant drugs Market Share, by Low molecular Heparin type, 2018 and 2025
  • 6.2. Heparin sodium
    • 6.2.1. Global Peptide and Anticoagulant Drugs Market for Heparin sodium, 2016-2025 (USD Million)
  • 6.3. Enoxaparin Sodium
    • 6.3.1. Global Peptide and Anticoagulant Drugs Market for Enoxaparin sodium, 2016-2025 (USD Million)
  • 6.4. Dalteparin Sodium
    • 6.4.1. Global Peptide and Anticoagulant Drugs Market for Dalteparin Sodium, 2016-2025 (USD Million)
  • 6.5. Fondaparinux
    • 6.5.1. Global Peptide and Anticoagulant Drugs Market for Fondaparinux, 2016-2025 (USD Million)
•  
• Chapter 7. Global Peptide and Anticoagulant Drugs Market - Application Analysis
  • 7.1. Global Peptide and Anticoagulant Drugs Market: Application overview
    • 7.1.1. Global Peptide and Anticoagulant Drugs Market Share, by Application, 2018 and 2025
  • 7.2. Infectious disease
    • 7.2.1. Global Peptide and Anticoagulant Drugs Market for infectious disease, 2016-2025 (USD Million)
  • 7.3. Gynecology
    • 7.3.1. Global Peptide and Anticoagulant Drugs Market for gynecology, 2016-2025 (USD Million)
  • 7.4. Cancer
    • 7.4.1. Global Peptide and Anticoagulant Drugs Market for cancer, 2016-2025 (USD Million)
  • 7.5. Diabetes
    • 7.5.1. Global Peptide and Anticoagulant Drugs Market for diabetes, 2016-2025 (USD Million)
  • 7.6. Cardiology
    • 7.6.1. Global Peptide and Anticoagulant Drugs Market for cardiology, 2016-2025 (USD Million)
  • 7.7. osteoporosis
    • 7.7.1. Global Peptide and Anticoagulant Drugs Market for osteoporosis 2016-2025 (USD Million)
  • 7.8. Others
    • 7.8.1. Global Peptide and Anticoagulant Drugs Market for Others, 2016-2025 (USD Million)
•  
• Chapter 8. Global Peptide and Anticoagulant Drugs Market - Regional Analysis
  • 8.1. Global Peptide and Anticoagulant drugs Market: Regional overview
    • 8.1.1. Global Peptide and Anticoagulant drugs Market Share, by region, 2018 and 2025
  • 8.2. North America
    • 8.2.1. North America Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
    • 8.2.2. North America Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
    • 8.2.3. North America Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
    • 8.2.4. The U.S.
      • 8.2.4.1. The U.S. Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
      • 8.2.4.2. The U.S. Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
      • 8.2.4.3. The U.S. Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
    • 8.2.5. Rest of North America
      • 8.2.5.1. Rest of North America Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
      • 8.2.5.2. Rest of North America Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
      • 8.2.5.3. Rest of North America Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
    • 8.3.2. Europe Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
    • 8.3.3. Europe Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
    • 8.3.4. Germany
      • 8.3.4.1. Germany Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
      • 8.3.4.2. Germany Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
      • 8.3.4.3. Germany Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
    • 8.3.5. U.K.
      • 8.3.5.1. U.K. Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
      • 8.3.5.2. U.K. Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
      • 8.3.5.3. U.K. Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
    • 8.3.6. France
      • 8.3.6.1. France Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
      • 8.3.6.2. France Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
      • 8.3.6.3. France Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
    • 8.3.7. Rest of Europe
      • 8.3.7.1. Rest
      • of Europe Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
      • 8.3.7.2. Rest of Europe Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
      • 8.3.7.3. Rest
      • of Europe Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
    • 8.4.2. Asia Pacific Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
    • 8.4.3. Asia Pacific Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. China Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
      • 8.4.4.2. China Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
      • 8.4.4.3. China Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
    • 8.4.5. Japan
      • 8.4.5.1. Japan Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
      • 8.4.5.2. Japan Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
      • 8.4.5.3. Japan Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
    • 8.4.6. India
      • 8.4.6.1. India Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
      • 8.4.6.2. India Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
      • 8.4.6.3. India Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
    • 8.4.7. Rest of Asia Pacific
      • 8.4.7.1. Rest of Asia Pacific Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
      • 8.4.7.2. Rest of Asia Pacific Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
      • 8.4.7.3. Rest of Asia Pacific Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
    • 8.5.2. Latin America Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
    • 8.5.3. Latin America Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
    • 8.5.4. Brazil
      • 8.5.4.1. Brazil Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
      • 8.5.4.2. Brazil Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
      • 8.5.4.3. Brazil Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
    • 8.5.5. Rest of Latin America
      • 8.5.5.1. Rest of Latin America Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
      • 8.5.5.2. Rest of Latin America Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
      • 8.5.5.3. Rest of Latin America Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
  • 8.6. The Middle East and Africa
    • 8.6.1. The Middle East and Africa Peptide and Anticoagulant Drugs Market Revenue, by type, 2016-2025 (USD Million)
    • 8.6.2. The Middle East and Africa Peptide and Anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016-2025 (USD Million)
    • 8.6.3. The Middle East and Africa Peptide and Anticoagulant Drugs Market Revenue, by Application, 2016-2025 (USD Million)
•  
• Chapter 9. Company Profile
  • 9.1. Sun Pharmaceutical Industries
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Product Portfolio
    • 9.1.4. Business strategy
    • 9.1.5. Recent developments
  • 9.2. Baxter
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Product Portfolio
    • 9.2.4. Business strategy
    • 9.2.5. Recent developments
  • 9.3. HemmoPharma
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Product Portfolio
    • 9.3.4. Business strategy
    • 9.3.5. Recent developments
  • 9.4. Celsus
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Product Portfolio
    • 9.4.4. Business strategy
    • 9.4.5. Recent developments
  • 9.5. AmbioPharm
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Product Portfolio
    • 9.5.4. Business strategy
    • 9.5.5. Recent developments
  • 9.6. Bachem
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Product Portfolio
    • 9.6.4. Business strategy
    • 9.6.5. Recent developments
  • 9.7. Pfizer
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Product Portfolio
    • 9.7.4. Business strategy
    • 9.7.5. Recent developments
  • 9.8. Abbott Laboratories
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Product Portfolio
    • 9.8.4. Business strategy
    • 9.8.5. Recent developments
  • 9.9. Aspen
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Product Portfolio
    • 9.9.4. Business strategy
    • 9.9.5. Recent developments
  • 9.10. Takeda
    • 9.10.1. Overview
    • 9.10.2. Financials
    • 9.10.3. Product Portfolio
    • 9.10.4. Business strategy
    • 9.10.5. Recent developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Peptide and Anticoagulant Drugs Market Revenue, 2016–2025 (USD Million) 
4. Porter’s Five Forces Analysis
5. Peptide and anticoagulant drugs Market attractiveness analysis, by type
6. Peptide and anticoagulant drugs Market attractiveness analysis, by lower molecular Heparin type
7. Peptide and anticoagulant drugs Market attractiveness analysis, by Application
8. Peptide and anticoagulant drugs Market attractiveness analysis, by Region
9. Company market share analysis, 2018
10. Global peptide and anticoagulant drugs market share by type, 2018 and 2025
11. Global peptide and anticoagulant drugs market revenue for antifungal, 2016–2025 (USD Million)
12. Global peptide and anticoagulant drugs market revenue for hormonal, 2016–2025 (USD Million)
13. Global peptide and anticoagulant drugs market revenue for ace inhibitors, 2016–2025 (USD Million)
14. Global peptide and anticoagulant drugs market revenue for antibiotics, 2016–2025 (USD Million)
15. Global peptide and anticoagulant drugs market revenue for other drugs, 2016–2025 (USD Million)
16. Global peptide and anticoagulant drugs market revenue share by low molecular Heparin type, 2018 and 2025
17. Global peptide and anticoagulant drugs market revenue for heparin sodium, 2016–2025 (USD Million)
18. Global peptide and anticoagulant drugs market revenue for enoxaparin sodium, 2016–2025 (USD Million)
19. Global peptide and anticoagulant drugs market revenue for Dalteparin sodium, 2016–2025 (USD Million)
20. Global peptide and anticoagulant drugs market revenue for Fondaparinux, 2016–2025 (USD Million)
21. Global peptide and anticoagulant drugs market revenue share by application, 2018 and 2025
22. Global peptide and anticoagulant drugs market revenue for infectious disease, 2016–2025 (USD Million)
23. Global peptide and anticoagulant drugs market revenue for gynecology, 2016–2025 (USD Million)
24. Global peptide and anticoagulant drugs market revenue for cancer, 2016–2025 (USD Million)
25. Global peptide and anticoagulant drugs market revenue for diabetes, 2016–2025 (USD Million)
26. Global peptide and anticoagulant drugs market revenue for cardiology, 2016–2025 (USD Million)
27. Global peptide and anticoagulant drugs market revenue for osteoporosis, 2016–2025 (USD Million)
28. Global peptide and anticoagulant drugs market revenue for others, 2016–2025 (USD Million)
29. North America peptide and anticoagulant drugs market revenue, 2016–2025 (USD Million)
30. Europe peptide and anticoagulant drugs market revenue, 2016–2025 (USD Million)
31. Asia Pacific peptide and anticoagulant drugs market revenue, 2016–2025 (USD Million)
32. Latin America peptide and anticoagulant drugs market revenue, 2016–2025 (USD Million)
33. The Middle East and Africa peptide and anticoagulant drugs market revenue, 2016–2025 (USD Million)

Table Of Tables

List of Tables

1. Peptide and anticoagulant drugs Market: Market snapshot
2. Drivers of the global peptide and anticoagulant drugs market: Impact analysis
3. Restraints of the global peptide and anticoagulant drugs market: Impact analysis
4. North America peptide and anticoagulant drugs market revenue, by type, 2016–2025 (USD Million)
5. North America peptide and anticoagulant drugs market revenue, by lower molecular Heparin type, 2016–2025 (USD Million)
6. North America peptide and anticoagulant drugs market revenue, by application, 2016–2025 (USD Million)
7. The U.S. Peptide and anticoagulant Drugs Market Revenue, by type, 2016–2025 (USD Million)
8. The U.S. Peptide and anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016–2025 (USD Million)
9. The U.S. Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)
10. Rest of North America Peptide and anticoagulant Drugs Market Revenue, by type, 2016–2025 (USD Million)
11. Rest of North America Peptide and anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016–2025 (USD Million)
12. Rest of North America Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)
13. Europe Peptide and anticoagulant Drugs Market Revenue, by type, 2016–2025 (USD Million)
14. Europe Peptide and anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016–2025 (USD Million)
15. Europe Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)
16. Germany Peptide and anticoagulant Drugs Market Revenue, by type, 2016–2025 (USD Million)
17. Germany Peptide and anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016–2025 (USD Million)
18. Germany Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)
19. U.K. Peptide and anticoagulant Drugs Market Revenue, by type, 2016–2025 (USD Million)
20. U.K. Peptide and anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016–2025 (USD Million)
21. U.K. Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)
22. France Peptide and anticoagulant Drugs Market Revenue, by type, 2016–2025 (USD Million)
23. France Peptide and anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016–2025 (USD Million)
24. France Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)
25. Rest of Europe Peptide and anticoagulant Drugs Market Revenue, by  type, 2016–2025 (USD Million)
26. Rest of Europe Peptide and anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016–2025 (USD Million)
27. Rest of Europe Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)
28. Asia Pacific Peptide and anticoagulant Drugs Market Revenue, by type, 2016–2025 (USD Million)
29. Asia Pacific Peptide and anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016–2025 (USD Million)
30. Asia Pacific Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)
31. China Peptide and anticoagulant Drugs Market Revenue, by type, 2016–2025 (USD Million)
32. China Peptide and anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016–2025 (USD Million)
33. China Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)
34. Japan Peptide and anticoagulant Drugs Market Revenue, by type, 2016–2025 (USD Million)
35. Japan Peptide and anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016–2025 (USD Million)
36. Japan Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)
37. India Peptide and anticoagulant Drugs Market Revenue, by type, 2016–2025 (USD Million)
38. India Peptide and anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016–2025 (USD Million)
39. India Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)
40. Rest of Asia Pacific Peptide and anticoagulant Drugs Market Revenue, by type, 2016–2025 (USD Million)
41. Rest of Asia Pacific Peptide and anticoagulant drugs Market Revenue, by low molecular Heparin type, by Assay, 2016–2025 (USD Million)
42. Rest of Asia Pacific Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)
43. Latin America Peptide and anticoagulant Drugs Market Revenue, by type, 2016–2025 (USD Million)
44. Latin America Peptide and anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016–2025 (USD Million)
45. Latin America Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)
46. Brazil Peptide and anticoagulant Drugs Market Revenue, by type, 2016–2025 (USD Million)
47. Brazil Peptide and anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016–2025 (USD Million)
48. Brazil Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)
49. Rest of Latin America Peptide and anticoagulant Drugs Market Revenue, by type, 2016–2025 (USD Million)
50. Rest of Latin America Peptide and anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016–2025 (USD Million)
51. Rest of Latin America Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)
52. The Middle East and Africa Peptide and anticoagulant Drugs Market Revenue, by type, 2016–2025 (USD Million)
53. The Middle East and Africa Peptide and anticoagulant Drugs Market Revenue, by low molecular Heparin type, 2016–2025 (USD Million)
54. The Middle East and Africa Peptide and anticoagulant Drugs Market Revenue, by Application, 2016–2025 (USD Million)